🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Mastocytosis

A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany NCT07255638n/a12 sites📍 Berlin📍 Bochum📍 Deggendorf Blueprint Medicines Corporation · Tests: Avapritinib Study of Factors Regulating Mast Cell Proliferation NCT00044122n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis NCT07142473n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Myeloproliferative Neoplasms (MPNs) Patient Registry NCT02760238n/a1 site📍 Toronto University Health Network, Toronto · Tests: Observational Avapritinib Rollover Study NCT06748001Phase 47 sites📍 Edegem📍 Toronto📍 Salerno Blueprint Medicines Corporation · Tests: Avapritinib Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis NCT06440148n/a1 site📍 Lublin Medical University of Lublin · Tests: SCLEROSTIN Avapritinib With Decitabine in Patients With SM-AHN NCT06327685Phase 17 sites📍 Phoenix📍 Palo Alto📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Avapritinib, Decitabine, Decitabine/Cedazuridine Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations NCT07143669n/a26 sites📍 Birmingham📍 Birmingham📍 Scottsdale Blueprint Medicines Corporation · Tests: Screening Mastocytosis Registry (of Zurich) NCT06466889n/a1 site📍 Zurich University of Zurich (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis NCT04910685Phase 2, Phase 388 sites📍 Birmingham📍 La Jolla📍 Los Angeles Blueprint Medicines Corporation · Tests: Elenestinib, Placebo Angioedema Biomarker Research Study NCT06210698n/a1 site📍 Wheaton Foundation For Rare Disease Research · Tests: Venipuncture Institutional Registry of Rare Diseases NCT06573723n/a1 site📍 Buenos Aires Hospital Italiano de Buenos Aires An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM) NCT07264959n/a7 sites📍 Aurora📍 Normal📍 Wheaton Blueprint Medicines Corporation (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis NCT04996875Phase 242 sites📍 Birmingham📍 Phoenix📍 Duarte Cogent Biosciences, Inc. · Tests: bezuclastinib Analysis of the Role of IgE Proteoforms in Health and Disease NCT07328178n/a1 site📍 Leuven KU Leuven · Tests: Blood sample collection Epidemiological Data on Mast Cell Pathologies in France NCT06186856n/a21 sites📍 Amiens📍 Angers📍 Besançon Imagine Institute Registry of Older Patients With Cancer NCT01137825n/a7 sites📍 Boone📍 Chapel Hill📍 Greenville UNC Lineberger Comprehensive Cancer Center Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis NCT07562542n/a1 site📍 Suzhou The First Affiliated Hospital of Soochow University Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy